Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FORMA THERAPEUTICS HOLDINGS, INC.

(FMTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

FORMA THERAPEUTICS HOLDINGS, INC. : Results of Operations and Financial Condition (form 8-K)

05/14/2021 | 07:35am EDT

Item 2.02 Results of Operations and Financial Condition

On May 14, 2021, Forma Therapeutics Holdings, Inc. announced its financial results for the quarter ended March 31, 2021. A copy of the press release is being furnished as Exhibit 99.1 to this Report on Form 8-K.

The information in this Item 2.02 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.


Item 9.01. Exhibits


(d) Exhibits



         Press release issued by Forma Therapeutics Holdings, Inc. on May 14,
99.1   2021, furnished herewith.




                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about FORMA THERAPEUTICS HOLDINGS, INC.
06/14FORMA THERAPEUTICS  : Announces Appointment of Industry Veteran John E. Bishop, ..
PU
06/14FORMA THERAPEUTICS HOLDINGS, INC.  : Change in Directors or Principal Officers, ..
AQ
06/14FORMA THERAPEUTICS  : Announces Appointment of Industry Veteran John E. Bishop, ..
BU
06/11FORMA THERAPEUTICS  : SVB Leerink Adjusts Forma Therapeutics Holdings PT to $54 ..
MT
06/11FORMA THERAPEUTICS  : Presents New Phase 1 Data on Etavopivat (formerly referred..
PU
06/11FORMA THERAPEUTICS HOLDINGS, INC.  : Regulation FD Disclosure, Other Events (for..
AQ
06/11FORMA THERAPEUTICS  : Presents New Phase 1 Data on Etavopivat (formerly referred..
BU
05/20FORMA THERAPEUTICS  : to Present Data from Pivotal Phase 2 Trial of Olutasidenib..
BU
05/17FORMA THERAPEUTICS  : to Participate in Upcoming Investor Conferences
BU
05/14FORMA THERAPEUTICS  : Management's Discussion and Analysis of Financial Conditio..
AQ
More news